To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Why The Oncology Institute’s merger with Deerfield’s SPAC is the first of its kind, PSG-backed Lumaverse awaits 2nd round bids
The Oncology Institute jump-starts next wave of value-based care while PSG's Lumaverse seeks buyer.
